CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Cipla USA, Inc. recalls Fosfomycin Tromethamine Granules for Oral…

Cipla USA, Inc. recalls Fosfomycin Tromethamine Granules for Oral Solution

Read the official FDA notice

Published
14 Oct 2026
Units affected
N/A
Agency
FDA
Country
United States

The hazard

Failed Impurities/Degradation Specifications

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Fosfomycin Tromethamine Granules for Oral Solution, (Equivalent to 3 Grams of Fosfomycin), 1 Single-Dose Sachet, Rx only, Manufactured by: Cipla Ltd., Kurkumbh-413802, Maharashtra, India, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-579-67.

Brand / company
Cipla USA, Inc.
Codes / lots
Lot#: 5KA0405, Exp 12/31/2026.
Distribution
USA Nationwide.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 14 Oct 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.